BRAINLIFE.ORG





Neuro-Oncology Reviews




Volume 26 Number 22
10 October 2024




Home > Publications > Neuro-Oncology Reviews > Volume 26, Year 2024 > Number 22, 10 October








Bhardwaj JS, Paliwal S, Singhvi G, Taliyan R.
Immunological challenges and opportunities in glioblastoma multiforme: A comprehensive view from immune system lens.
Life Sci. 2024 Oct 1;357:123089. doi: 10.1016/j.lfs.2024.123089. PMID: 39362586. Review˰ ˍ




Okon II, Osama M, Akpan A, Fabrini Paleare LF, Ferreira MY, Shafqat MD, Razouqi Y, James E, Omer M, Ja'afar IK, Chaurasia B, Iqbal M, Balogun S, Maidan A, Hussain Jakhar MO, Precious FK, Gbayisomore TJ, Lucero-Prisno DE 3rd.
The Evolving Role of Palliative Care in older people with Glioblastoma.
World Neurosurg. 2024 Oct 1:S1878-8750(24)01674-7. doi: 10.1016/j.wneu.2024.09.125. PMID: 39362596. Review˰ ˍ




*Alnahhas I.
Molecular Testing in Gliomas: What is Necessary in Routine Clinical Practice?
Curr Oncol Rep. 2024 Oct 3. doi: 10.1007/s11912-024-01602-w. PMID: 39361075. Review. ˍ




**Magnon C.
What a wonderful world!
Genes Dev. 2024 Oct 3;38(17-20):802-804. doi: 10.1101/gad.352278.124. PMID: 39362781. Meeting report. ˍ




Bourbonne V, Ollivier L, Antoni D, Pradier O, Cailleteau A, Schick U, Noël G, Lucia F.
Diagnosis and management of brain radiation necrosis.
Cancer Radiother. 2024 Oct 4:S1278-3218(24)00141-0. doi: 10.1016/j.canrad.2024.07.014. PMID: 39366819. Review˰ ˍ




Jelski W, Mroczko B.
MicroRNAs as Biomarkers of Brain Tumor.
Cancer Manag Res. 2024 Oct 4;16:1353-1361. doi: 10.2147/CMAR.S484158. PMID: 39380890. Review. ˍ




Karimi-Sani I, Molavi Z, Naderi S, Mirmajidi SH, Zare I, Naeimzadeh Y, Mansouri A, Tajbakhsh A, Savardashtaki A, Sahebkar A.
Personalized mRNA vaccines in glioblastoma therapy: from rational design to clinical trials.
J Nanobiotechnology. 2024 Oct 4;22(1):601. doi: 10.1186/s12951-024-02882-x. PMID: 39367418. Review. ˍ




Cui J, Zou X, Han Y, Jiang J.
Benign extracranial meningioma with pulmonary metastasis: a case report and review of literature.
J Med Case Rep. 2024 Oct 5;18(1):461. doi: 10.1186/s13256-024-04800-z. PMID: 39367495. Case report; Review. ˍ




Jiwei B, Abulimiti M, Yonglong J, Jie W, Shuyan Z, Chao L, Zishen W, Wei W, Yinuo L, Weiwei W, Lu Y, Shimizu S.
Proton beam therapy in a patient with secondary glioblastoma (32 years after postoperative irradiation of medulloblastoma): case report and literature review.
Radiat Oncol. 2024 Oct 5;19(1):136. doi: 10.1186/s13014-024-02515-5. PMID: 39369243. Case report; Review. ˍ




Wen PY, Preusser M, Albert NL.
Design and conduct of theranostic trials in neuro-oncology: Challenges and opportunities.
Neuro Oncol. 2024 Oct 5:noae162. doi: 10.1093/neuonc/noae162. PMID: 39368109. Review. ˍ




Bennebroek CA, Montauban van Swijndregt MC, van Zwol J, Bhusal S, Dittrich AT, Oostenbrink R, Pott JWR, Buijs EA, Schouten-van Meeteren AY, Porro GL, de Graaf P, Saeed P.
Treatment of isolated pediatric optic nerve glioma: A nationwide retrospective cohort study and systematic literature review on visual and radiological outcome.
Pediatr Blood Cancer. 2024 Oct 8:e31358. doi: 10.1002/pbc.31358. PMID: 39380191. Observational study; Review. ˍ




Levine AB, Hawkins CE.
Molecular markers for pediatric low-grade glioma.
Childs Nerv Syst. 2024 Oct 8. doi: 10.1007/s00381-024-06639-7. PMID: 39379532. Review˰ ˍ




Lim-Fat MJ, Roberto K, Wen PY.
Clinical trial design for novel targeted agents in neuro-oncology.
J Neurooncol. 2024 Oct 8. doi: 10.1007/s11060-024-04846-5. PMID: 39377992. Review˰ ˍ




Rathi A, Choudhari AK, Chatterjee A, Sahay A, Bhattacharya K, Sahu A, Puranik AD, Shah A, Dasgupta A, Gupta T, Epari S.
Spinal Diffuse Midline Glioma H3K27M-Altered: Report of a Rare Tumor with Extracranial Skeletal Metastases and Review of Literature.
Int J Surg Pathol. 2024 Oct 8:10668969241286243. doi: 10.1177/10668969241286243. PMID: 39376094. Case report; Review˰ ˍ




*Sandhanam K, Tamilanban T, Bhattacharjee B, Manasa K.
Exploring miRNA therapies and gut microbiome-enhanced CAR-T cells: advancing frontiers in glioblastoma stem cell targeting.
Naunyn Schmiedebergs Arch Pharmacol. 2024 Oct 9. doi: 10.1007/s00210-024-03479-9. PMID: 39382681. Review˰ ˍ




Stormezand GN, de Meyer E, Koopmans KP, Brouwers AH, Luurtsema G, Dierckx RAJO.
Update on the Role of [18F]FDOPA PET/CT.
Semin Nucl Med. 2024 Oct 9:S0001-2998(24)00080-1. doi: 10.1053/j.semnuclmed.2024.09.004. PMID: 39384519. Review. ˍ








*Pan J, Eskandar T, Ahmed Z, Agrawal DK.
Biophysical and Biological Mechanisms of Tumor Treating Fields in Glioblastoma.
J Cancer Sci Clin Ther. 2024 Aug 19;8(3):265-270. doi: 10.26502/jcsct.5079249. PMID: 39364266. Perspective. ˍ




Rath S, Shafeea MS, Abdul Hussein AF, Shamil Hashim A, Hassanaien S, Pastrana-Brandes S, Chaurasia B.
CAR-T-cell therapy in meningioma: current investigations, advancements and insight into future directions.
Ann Med Surg (Lond). 2024 Aug 22;86(10):5957-5965. doi: 10.1097/MS9.0000000000002491. PMID: 39359850. Review. ˍ




Paltin I, Sy M, Lundy SM, Ayr-Volta LK, Canale R, Fong G, Janke K, Pfeifle GB, Quinton T, Schofield HL, Warren EAH.
Neuropsychological Late Effects and Quality-of-Life Outcomes in Pediatric Brain Tumor Survivors: Role of Pediatric Neurologists in Monitoring and Management.
Pediatr Neurol. 2024 Sep 7;161:149-157. doi: 10.1016/j.pediatrneurol.2024.08.014. PMID: 39383589. Review˰ ˍ




Sterner RC, Sterner RM.
EGFRVIII and EGFR targeted chimeric antigen receptor T cell therapy in glioblastoma.
Front Oncol. 2024 Sep 19;14:1434495. doi: 10.3389/fonc.2024.1434495. PMID: 39364321. Review. ˍ




Saqib M, Zahoor A, Rahib A, Shamim A, Mumtaz H.
Clinical and translational advances in primary brain tumor therapy with a focus on glioblastoma-A comprehensive review of the literature.
World Neurosurg X. 2024 Sep 21;24:100399. doi: 10.1016/j.wnsx.2024.100399. PMID: 39386927. Review. ˍ




Cao S, Wei Y, Yue Y, Wang D, Yang J, Xiong A, Zeng H.
Mapping the evolution and research landscape of ferroptosis-targeted nanomedicine: insights from a scientometric analysis.
Front Pharmacol. 2024 Sep 25;15:1477938. doi: 10.3389/fphar.2024.1477938. PMID: 39386034. Bibliometric analysis. ˍ




Mittelbronn M.
Neurooncology: 2024 update.
Free Neuropathol. 2024 Sep 27;4:21. doi: 10.17879/freeneuropathology-2024-5809. PMID: 39385753. Review. ˍ




Wu J, Wang N.
Current progress of anti-PD-1/PDL1 immunotherapy for glioblastoma (Review).
Mol Med Rep. 2024 Sep 30;30(6):221. doi: 10.3892/mmr.2024.13344. PMID: 39364736. Review. ˍ